BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 20, 2013
View Archived Issues
Quantitative, non-invasive, magnetic resonance imaging of tumor metabolism in vivo
Read More
Identification of a novel clinical biomarker for a specific subset of patients with breast cancer
Read More
Phase I clinical evaluation of a sporozoite-based vaccine for immunization against malaria
Read More
LIDDS reports data from second phase IIa study of Liproca Depot
Read More
Researchers highlight the relevance of BAP1 mutations in melanoma
Read More
Retrophin to exclusively negotiate development rights for autism and schizophrenia treatment
Read More
Retrophin reports RE-024 preclinical results
Read More
FDA approves GSK's FluLaval Quadrivalent influenza virus vaccine
Read More
Australian government provides grant to Aeras for tuberculosis vaccine
Read More
New MGAT2 inhibitors for hypertriglyceridemia presented by Eli Lilly
Read More
Taiho Pharmaceutical designs novel agents for urinary incontinence
Read More
Selexys commences with SUSTAIN phase II trial
Read More
Roche and Genentech disclose new MEKKK4 inhibitors
Read More
Actelion synthesizes new chemokine CXCR3 receptor modulators
Read More
French authorities grant market access to Pixuvri for aggressive non-Hodgkin's lymphoma
Read More
Toyama Chemical Co. presents novel products for HIV infection
Read More
Tau Therapeutics collaborator receives grant for glioblastoma reserach
Read More
BIND Therapeutics initiates dosing in phase II PSMA-targeting study
Read More
GenSpera raises funds for G-202 development
Read More
to-BBB to proceed to phase IIa 2B3-101 study
Read More
GTx' POWER trials fail to meet primary endpoints
Read More
Wanbang Pharma to develop Sirona Biochem's SGLT2 inhibitor in China
Read More
FDA approves Trokendi XR launch
Read More
Japanese researchers divulge new tubulin polymerization inhibitors
Read More
Japanese authorities approve Bayer's Stivarga for GIST
Read More